SCHEMBL30217068

SCHEMBL30217068

OC(c1cccc(I)c1)c1nnc(-c2cc(Oc3c(F)cc4[nH]ccc4c3F)ccc2F)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30217210 0.81 — —
SCHEMBL30217167 0.78 DRD1 (0.30) —
SCHEMBL29237447 0.77 — —
SCHEMBL30217274 0.77 — —
SCHEMBL30967780 0.76 PTGS1 (0.32) —
SCHEMBL30967854 0.74 DRD1 (0.36) —
SCHEMBL30217195 0.74 THRA (0.34) —
SCHEMBL29237346 0.74 THRA (0.34) —
SCHEMBL29237520 0.73 MAOA (0.32) —
SCHEMBL29237271 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4396179-A1 INDOLE COMPOUNDS AND METHODS OF USE GENZYME CORPORATION (US) 2024-07-10 — — EP disclosed
CN-118201919-A Indole compounds and methods of use 健赞公司 2024-06-14 — — CN disclosed
WO-2023034992-A1 INDOLE COMPOUNDS AND METHODS OF USE GENZYME CORPORATION (US) 2023-03-09 — — WO disclosed
Send feedback